Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production

By Hall G.   Houghton C.G.   Rahbek J.U.   Lamb J.R.   Jarman E.R.  

Vaccine, Vol. 21, Iss. 5, 2003-01 ,pp. : 549-561

Elsevier

Access to resources Recommend Favorite

Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents

By Ben-Yehuda A.   Joseph A.   Barenholz Y.   Zeira E.   Even-Chen S.   Louria-Hayon I.   Babai I.   Zakay-Rones Z.   Greenbaum E.   Galprin I.   Gluck R.   Zurbriggen R.   Kedar E.  

Vaccine, Vol. 21, Iss. 23, 2003-07 ,pp. : 3169-3178

Elsevier

Access to resources Recommend Favorite

Comparison of the quality of protection elicited by toxoid and peptide liposomal vaccine formulations against ricin as assessed by markers of inflammation

By Griffiths G.D.   Phillips G.J.   Bailey S.C.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2562-2568

Elsevier

Access to resources Recommend Favorite

Liposomal vaccine delivery systems

By Henriksen-Lacey Malou   Korsholm Karen Smith   Andersen Peter   Perrie Yvonne   Christensen Dennis  

Expert Opinion on Drug Delivery, Vol. 8, Iss. 4, 2011-04 ,pp. : 505-519

Informa Healthcare

Access to resources Recommend Favorite

A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2

By Wong H.-T.   Cheng S.C.-S.   Sin F.W.-Y.   Chan E.W.-C.   Sheng Z.-T.   Xie Y.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2641-2647

Elsevier

Access to resources Recommend Favorite